Sofia Heigis
Chief Executive Officer at ONCOPEPTIDES AB
Net worth: 12 221 $ as of 2024-03-30
Profile
Sofia Heigis is currently the Chief Executive Officer at Oncopeptides AB.
Previously, she worked at AstraZeneca R & D Lund as the Head of Medical & Regulatory Affairs.
Ms. Heigis has a graduate degree from Bond University and an undergraduate degree from the University of Gothenburg.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ONCOPEPTIDES AB
0.02% | 2022-12-30 | 20,104 ( 0.02% ) | 12 221 $ | 2024-03-30 |
Sofia Heigis active positions
| Companies | Position | Start |
|---|---|---|
| ONCOPEPTIDES AB | Chief Executive Officer | 2023-08-06 |
Former positions of Sofia Heigis
| Companies | Position | End |
|---|---|---|
| AstraZeneca R & D Lund | Chief Tech/Sci/R&D Officer | - |
Training of Sofia Heigis
| Bond University | Graduate Degree |
| University of Gothenburg | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ONCOPEPTIDES AB | Health Technology |
| Private companies | 1 |
|---|---|
| AstraZeneca R & D Lund |
- Stock Market
- Insiders
- Sofia Heigis
